Published in Neurology on September 01, 1986
Evidence for a non-orthostatic origin of orthostatic tremor. J Neurol Neurosurg Psychiatry (1999) 1.43
Slow orthostatic tremor in multiple sclerosis. Mov Disord (2009) 1.02
Orthostatic tremor in three brothers. J Neurol (2007) 1.01
Tremor disorders. Diagnosis and management. West J Med (1995) 0.96
Orthostatic Tremor: A Spectrum of Fast and Slow Frequencies or Distinct Entities? Tremor Other Hyperkinet Mov (N Y) (2015) 0.85
Orthostatic Tremor: An Update on a Rare Entity. Tremor Other Hyperkinet Mov (N Y) (2016) 0.81
Familial orthostatic tremor and essential tremor in two young brothers: A rare entity. Ann Indian Acad Neurol (2013) 0.76
Orthostatic tremor: diagnostic entity or variant of essential tremor? J Neurol Neurosurg Psychiatry (1989) 0.76
Orthostatic Tremor and Orthostatic Myoclonus: Weight-bearing Hyperkinetic Disorders: A Systematic Review, New Insights, and Unresolved Questions. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell (2001) 4.25
Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet (1997) 4.12
Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron (1997) 3.73
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A (2013) 2.31
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology (2008) 2.17
Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology (2006) 2.17
Acute rheumatic fever and carditis in older adults. Lancet (1966) 2.01
Hereditary adult-onset Alexander's disease with palatal myoclonus, spastic paraparesis, and cerebellar ataxia. Neurology (1995) 1.79
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67
Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nat Genet (1995) 1.51
Familial patterns of prostate cancer: a case-control analysis. J Urol (1991) 1.45
A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet (1996) 1.45
Hereditary nonprogressive chorea of early onset. N Engl J Med (1967) 1.39
Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am J Hum Genet (1994) 1.38
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology (2012) 1.35
Brain scans at varied intervals following C. V. A. J Nucl Med (1965) 1.32
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord (2010) 1.29
Linkage studies in spinocerebellar ataxia (SCA). Am J Med Genet (1980) 1.25
Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. Neurology (2002) 1.20
Progression rate and age at onset are related in autosomal dominant neurologic diseases. Neurology (1982) 1.19
A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology (2000) 1.16
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis (2013) 1.15
Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease. Ann Neurol (1995) 1.15
Interactions between coilin and PIASy partially link Cajal bodies to PML bodies. J Cell Sci (2005) 1.13
Common demyelinating and degenerative diseases and extrapyramidal disorders--panel 4. Arch Neurol (1979) 1.08
Tick paralysis. Semin Neurol (2004) 1.08
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol (2005) 1.04
Amyotrophic lateral sclerosis and metallic toxins. Arch Environ Health (1968) 1.04
Multiple sclerosis and amyotrophic lateral sclerosis in Mississippi. Neurology (1967) 1.02
Bilateral ptosis due to mesencephalic lesions with relative preservation of ocular motility. J Neuroophthalmol (1996) 1.00
Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia. FEBS Lett (2006) 0.99
Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology (1998) 0.97
Calcium homeostasis and spinocerebellar ataxia-1 (SCA-1). Brain Res Bull (2001) 0.97
Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J Mol Neurosci (2012) 0.96
Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab (2013) 0.93
Spinocerebellar ataxia: study of a large kindred. I. General information and genetics. Neurology (1972) 0.93
Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice. Brain Res Bull (2006) 0.92
Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol (1995) 0.90
Possible risk factors in multiple sclerosis as found in a national twin study. Arch Neurol (1982) 0.90
What is Kearns-Sayre syndrome after all? Arch Neurol (2001) 0.90
Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms. PLoS One (2013) 0.90
An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature. J Am Geriatr Soc (1976) 0.90
A two-and-a-half color rainbow. Color blindness in physicians. Arch Neurol (1994) 0.90
Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice. J Neurol Sci (2000) 0.90
Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol (2012) 0.89
Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci (1982) 0.89
Prior events in multiple sclerosis. Neurology (1974) 0.88
Health related quality of life measures in Friedreich Ataxia. J Neurol Sci (2008) 0.87
Linkage studies on glyoxalase I (GLO), pepsinogen (PG), spinocerebellar ataxia (SCA1), and HLA. Cytogenet Cell Genet (1980) 0.87
Familial progressive subcortical gliosis. Neurology (1994) 0.86
Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum (2009) 0.85
Generalized myokymia and gold therapy. Arch Neurol (1982) 0.85
The Mississippi Regional Medical Program Stroke Unit. Critique and follow-up of the first 200 patients admitted. South Med J (1971) 0.85
Lack of cold sensitivity in hyperkalemic periodic paralysis. Muscle Nerve (1986) 0.85
Sequence variation in GAA repeat expansions may cause differential phenotype display in Friedreich's ataxia. Mov Disord (2001) 0.84
Scorpion venom and multiple sclerosis. Lancet (1983) 0.83
Analysis of the visual system in Friedreich ataxia. J Neurol (2013) 0.83
Steady or not following thalamic deep brain stimulation for essential tremor. J Neurol (2011) 0.83
Sciatic neuropathy induced by the lithotomy position. Arch Neurol (1983) 0.83
Morphometric studies in dominant olivopontocerebellar atrophy. Comparison of cell losses with amino acid decreases. Arch Neurol (1990) 0.83
Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis. Cell Reprogram (2013) 0.82
Brain scans of cerebral infarcts with radioactive mercury. Radiology (1967) 0.82
Elementary, my dear Dr. Allen: the case of barium toxicity and Pa Ping. Neurology (2010) 0.82
Survival in untreated cryptococcal meningitis. Neurology (1981) 0.82
Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Ann Neurol (1987) 0.81
Affective communication deficits associated with cerebellar degeneration. Neurocase (2012) 0.81
Autosomal dominant spinocerebellar ataxias ad infinitum? Neurology (2001) 0.81
Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuroophthalmol (2015) 0.80
Tick paralysis in children: electrophysiology and possibility of misdiagnosis. Neurology (2002) 0.80
Genetic linkage and spinocerebellar ataxia. Adv Neurol (1978) 0.80
Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing. J Neurosci Res (2007) 0.80
Unilateral asterixis: case report and comments. Eur Neurol (1986) 0.80
Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis. Neurosci Lett (2006) 0.79
Inositol 1,4,5-trisphosphate receptors and protein kinase C in olivopontocerebellar atrophy. Brain Res (1991) 0.79
Effect of keto-acidosis on seizure occurrence in diabetic patients. J Miss State Med Assoc (2005) 0.79
Coenzyme Q10 and spinocerebellar ataxias. Mov Disord (2014) 0.79
Force dysmetria in spinocerebellar ataxia 6 correlates with functional capacity. Front Hum Neurosci (2015) 0.79
Exercise and rest in hyperkalemic periodic paralysis. Neurology (1986) 0.78
Dominantly inherited ataxias. Semin Pediatr Neurol (2003) 0.78
Developmental changes in cerebellar endothelin-1 receptors in the neurologic mouse lurcher mutant. Res Commun Mol Pathol Pharmacol (1995) 0.78
Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1. Neurosci Lett (2007) 0.78
Dominantly inherited cerebello-olivary atrophy is not due to a mutation at the spinocerebellar ataxia-I, Machado-Joseph disease, or Dentato-Rubro-Pallido-Luysian atrophy locus. Mov Disord (1996) 0.78
Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia-1. Neurology (1996) 0.78
Vibrations and sounds produced during sustained voluntary muscle contraction. Electromyogr Clin Neurophysiol (1990) 0.78
The effects of calbindin D-28K and parvalbumin antisense oligonucleotides on the survival of cultured Purkinje cells. Res Commun Mol Pathol Pharmacol (1999) 0.78
Aspartate-taurine imbalance in dominantly inherited olivopontocerebellar atrophy. Neurology (1977) 0.77
Decreased insulin-like growth factor I-mediated protein tyrosine phosphorylation in human olivopontocerebellar atrophy and lurcher mutant mouse. J Neurol Sci (1994) 0.77
Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy. Eur Neurol (1986) 0.77
Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin. Pediatr Neurol (1995) 0.76
Identification of a new form of autosomal dominant spastic paraplegia. Clin Genet (2009) 0.76
Intrafamilial variability in Machado-Joseph disease. Mov Disord (1996) 0.76
Sexual seizures. Arch Neurol (1971) 0.76